Paul Tudor Jones’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,200
Closed -$301K 4004
2025
Q4
$301K Sell
1,200
-800
-40% -$212K ﹤0.01% 3052
2025
Q3
$574K Buy
2,000
+400
+25% +$107K ﹤0.01% 2614
2025
Q2
$420K Buy
1,600
+600
+60% +$146K ﹤0.01% 2701
2025
Q1
$233K Buy
1,000
+100
+11% +$24.3K ﹤0.01% 2767
2024
Q4
$206K Buy
+900
New +$206K ﹤0.01% 2829
2023
Q2
Sell
-1,280
Closed -$253K 2710
2023
Q1
$253K Sell
1,280
-1,514
-54% -$312K ﹤0.01% 2044
2022
Q4
$566K Buy
+2,794
New +$546K 0.01% 1502
2022
Q3
Sell
-2,095
Closed -$420K 2528
2022
Q2
$420K Buy
+2,095
New +$447K 0.01% 1366
2021
Q4
Sell
-3,143
Closed -$760K 2748
2021
Q3
$760K Buy
+3,143
New +$792K 0.01% 1355

Other funds holding LH

Paul Tudor Jones's LH Position: Q2 2026 in Review

Paul Tudor Jones sold out of Labcorp (LH) in Q2 2026, closing a stake of 1,520 shares — an estimated $406K sold.

Paul Tudor Jones first reported a position in LH in Q4 2013 and held it in 23 quarters. The position peaked at $30.9M in Q2 2016. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Paul Tudor Jones reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 1,520 Labcorp shares in Q2 2026, an estimated $406K.
  • Paul Tudor Jones first reported a position in Labcorp in Q4 2013 and held it in 23 quarters.
  • Paul Tudor Jones's Labcorp position peaked at $30.9M in Q2 2016.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.